The experimental drug has shown promise in early-stage clinical trials conducted in Singapore.

In the Chinese city of Chengdu, one-third of ride-sharing might replace public transit trips.

Company working with Sikes Lab to test feasibility of low-cost diagnostic that could be manufactured by the millions each day.

Modeling study shows battery reuse systems could be profitable for both electric vehicle companies and grid-scale solar operations.

Using engineered binder proteins to detect viral proteins or antibodies rather than RNA, new tests may overcome current challenges in testing for SARS-CoV-2 virus.

Hadley Sikes designs simple-to-use diagnostic devices that could benefit patients around the world.

Discovery explains why some bacteria have been able to defend against phage therapy, opens new ways to overcome existing challenges.

Carbon nanotubes embedded in leaves detect chemical signals that are produced when a plant is damaged.

Microfluidics enables researchers to create unique environment for developing medicine, paving the way for more potent, high-quality drugs.

Starting with higher-value niche markets and then expanding could help perovskite-based solar panels become competitive with silicon.